Corrections to “A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma”
Titel:
Corrections to “A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma”
Auteur:
Evens, A.M. Carson, K.R. Kolesar, J. Nabhan, C. Helenowski, I. Islam, N. Jovanovic, B. Barr, P.M. Caimi, P.F. Gregory, S.A. Gordon, L.I.